 |
Table 1. Antibiotics Investigated by the Division
of Infectious Diseases at CPMC |
Carbenicillin* |
Cefazaflur |
Amoxicillin* |
|
Cefsulodin* |
Tobramycin* |
Cefsulodin* |
Cefacetrile |
Moxalactam |
Cefanone |
|
Cefuperazone* |
Cefoxitin*
|
Trimethoprim |
|
Cefamandole*
|
Ticarcillin
|
Sulfamethoxazole* |
Ceftizoxime* |
Macillinam*
|
Thiamphanicol |
Netilimicin* |
Imipenem* |
Sisomicin |
|
Piperacillin* |
Amikacin* |
Ceftazidime* |
|
Iperacillin* |
Aztreonam*
|
Cefaclor* |
|
Tigemonam
|
Cefuroxime* |
Apalcillin |
|
Azlocillin*
|
Norfloxacin* |
Mezlocillin* |
|
Cefmenoxime
|
Netilmicin* |
Temocillin |
|
Ipemacin |
Fosmidomycin
|
5-Episisomicin |
|
0-Demethylfortimicin |
Cefotaxime* |
Cefodizime |
|
Clavulanate* |
Ofloxacin*
|
Sulbactamm* |
|
Enoxacin*
|
Enoxacin* |
Cefutriazine |
|
Pefloxacin
|
Courmermycin |
Cefixime* |
Amoxicillin/ clavulanate* |
Tecarcillin/ clavulanate*
|
Ampicillin/ sulbactam* |
|
Cefpirome
|
Cefepime |
Cefotetan* |
|
Cefpiramide
|
| |